Search for: "E Lewis" Results 1 - 20 of 2,935
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Privacy Policy: By subscribing to Liskow & LewisE-Communications, you will receive articles and blogs with insight and analysis of legal issues that may impact your industry. [read post]
21 May 2024, 8:17 am by Phil Dixon
This post summarizes published criminal and related decisions of interest from the Fourth Circuit Court of Appeals in April 2024. [read post]
17 May 2024, 6:30 am
Posted by Joel Paula, FCLTGlobal, on Monday, May 13, 2024 Tags: AI, Artificial intelligence, ESG, Glass Lewis, ISS The 2024 Audit Committee agenda and the questions investors should be asking Posted by Sophie Gauthier-Beaudoin and Tim Copnell, KPMG, on Tuesday, May 14, 2024 Tags: Audit committee, Audits, Cybersecurity, ESG, ESG disclosures, Financial reporting, Generative AI, Governance reform, investors The Distinction Between Direct and Derivative Shareholder Claims Posted by Jim… [read post]
17 May 2024, 6:30 am
Posted by Joel Paula, FCLTGlobal, on Monday, May 13, 2024 Tags: AI, Artificial intelligence, ESG, Glass Lewis, ISS The 2024 Audit Committee agenda and the questions investors should be asking Posted by Sophie Gauthier-Beaudoin and Tim Copnell, KPMG, on Tuesday, May 14, 2024 Tags: Audit committee, Audits, Cybersecurity, ESG, ESG disclosures, Financial reporting, Generative AI, Governance reform, investors The Distinction Between Direct and Derivative Shareholder Claims Posted by Jim… [read post]
13 May 2024, 10:00 pm by Sherica Celine
To help advise employers on legal and practical workplace mental health issues, see this superb practice note, Mental Health Issues as Work, by Jennifer Mathis, Lewis Bossing, and Sara Frank of the Bazelon Center for Mental Health Law. [read post]
9 May 2024, 2:00 pm by Joanna Herzik
The scammer’s phone number was 210-584-0452 and caller ID showed the scammer’s name as Kenneth Lewis. [read post]
6 May 2024, 4:43 am by INFORRM
Sir David Davis MP has tabled a number of far reaching amendments [pdf] to the  Strategic Litigation Against Public Participation Bill [pdf] which returns to the House of Commons for its Committee Stage on 8 May 2024. [read post]
Privacy Policy: By subscribing to Liskow & LewisE-Communications, you will receive articles and blogs with insight and analysis of legal issues that may impact your industry. [read post]
Privacy Policy: By subscribing to Liskow & LewisE-Communications, you will receive articles and blogs with insight and analysis of legal issues that may impact your industry. [read post]
30 Apr 2024, 3:12 pm by Bill Marler
Several bacteria, including E. coli, induce septic arthritis.[61] The resulting joint p [read post]
29 Apr 2024, 10:43 pm by Jocelyn Bosse
They pick up on their previous comments about whether section 9(3) CDPA on computer-generated works operates as an exception to the originality requirement, especially in light of the E&W Court of Appeal decision in THJ Systems v Sheridan. [read post]
29 Apr 2024, 2:40 am by INFORRM
On 25 April 2024, a federal judge upheld the verdict and award of more than $83m to the writer E Jean Carroll in a defamation case against Donald Trump after he called her a liar for accusing him of sexually assaulting her. [read post]
On April 10, 2024, the Environmental Protection Agency (“EPA”), under the Safe Drinking Water Act (“SDWA”), issued the final National Primary Drinking Water Regulation (“NPDWR”) that sets enforceable limits in drinking water for six per- and poly-fluoroalkyl substances (“PFAS”). [read post]
Privacy Policy: By subscribing to Liskow & LewisE-Communications, you will receive articles and blogs with insight and analysis of legal issues that may impact your industry. [read post]
16 Apr 2024, 6:35 am by Neil Abramson and Jeff Lieberman
Privacy Policy: By subscribing to Liskow & LewisE-Communications, you will receive articles and blogs with insight and analysis of legal issues that may impact your industry. [read post]
15 Apr 2024, 2:31 am by INFORRM
On Thursday 11 April 2024 there were hearings in the cases of Prospect v Evans KB-2024-00030 and McGee v Lewis KB-2023-002435. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]